Fri Jul 30 16:30:19 SGT 2010

SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550

Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Walk-in clinic. Appointments not required.
Bring NRIC, Visit Pass or Passport for registration.

Seasonal Flu/Influenza Vaccine Shot/Jab/Injection Singapore Clinic

Share |

Summary

Seasonal Flu/Influenza Vaccine Shot/Jab/Injection Singapore Clinic: Seasonal flu/influenza vaccine shot/jab/injection clinic, Singapore. For vaccination against seasonal flu/influenza - Definitions, references and latest news.

Description

We do not stock the seasonal flu/influenza vaccine.

Questions and Answers

Question: I am travelling overseas a few weeks from now. When is a good time for me to get the flu vaccine? Shall I have the flu vaccine a week or so just before the overseas trip?

Answer: No. You should have the flu vaccine as soon as possible. The longer the time before the trip, the more time your body would have to react to the vaccination, and build up your immunity against the seasonal flu. And hence provide you better protection during your overseas trip.

Question: Why should I be vaccinated with the seasonal flu vaccine?

Answer: It is worthwhile to be vaccinated against the seasonal flu viruses, as they are the ones which are responsible for the majority of the flu related morbidity and mortality, due to the accompanying opportunistic infections and complications. Every year, worldwide, seasonal flu is responsible for 500 million to 1 billion infections, and 250,000 to 500,000 deaths.

References

Latest News

South Africa: High Risk Patients Urged to Get H1N1 Jabs
Wed, 28 Jul 2010 13:35:50 +0100 | AllAfrica News: Health and Medicine
The Gauteng Department of Health and Social Development has urged high-risk patients to visit their nearest public health facility to get vaccinated against the H1N1 influenza. (Source: AllAfrica News: Health and Medicine)

Dynavax Completes Enrollment And First Immunizations In Universal Flu Vaccine Study
Wed, 28 Jul 2010 08:00:00 +0100 | Health News from Medical News Today
Dynavax Technologies Corporation (NASDAQ: DVAX) reported completing enrollment and the first immunizations of 39 subjects enrolled in its Phase 1 study of the company's Universal Flu vaccine. Safety and immunogenicity data from this study are anticipated in the fourth quarter of this year. The Phase 1 trial began vaccinating subjects in late June to assess the safety and immunogenicity of N8295, the novel component of Dynavax's Universal Flu vaccine candidate. Since that time, 39 subjects were divided into three dose groups... (Source: Health News from Medical News Today)

Sustained viral load and late death in Rag2-/- mice after influenza A virus infection
Tue, 27 Jul 2010 23:00:00 +0100 | Virology Journal
The importance of the adaptive immune response for secondary influenza infections and protection from a lethal challenge after vaccination has been well documented. However, some controversy still exists concerning the specific involvement of B and T cells during a primary infection. Here, we have followed the survival, weight loss, viral load and lung pathology in Rag2-/- knock-out mice after infection with influenza A virus (H1N1). Infected wild type mice initially lost weight early after infection but then cleared the virus and recovered. Rag2-/- mice, however, showed similar weight loss kinetics in the early stages after infection but weight loss continued post infection and culminated in death. In contrast to wild type mice, Rag2-/- mice were not able to clear the virus, despite an in...

Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010 [From the Centers for Disease Control and Prevention]
Tue, 27 Jul 2010 19:51:04 +0100 | JAMA
(Source: JAMA)

Gambia: H1N1 Pandemic Vaccination Campaign Begins
Tue, 27 Jul 2010 15:14:46 +0100 | AllAfrica News: Health and Medicine
The Ministry of Health and Social Welfare in collaboration with the World Health Organisation (WHO) yesterday started its nationwide vaccination campaign of Influenza A (H1N1) which is expected to last till 30th of July. (Source: AllAfrica News: Health and Medicine)

Dynavax starts universal flu vaccine test
Tue, 27 Jul 2010 13:23:00 +0100 | bizjournals.com Health Care:Health Insurance headlines
Dynavax Technologies Corp. started early testing of its universal flu vaccine. (DVAX) (Source: bizjournals.com Health Care:Health Insurance headlines)

Dynavax starts universal flu vaccine test
Tue, 27 Jul 2010 13:23:00 +0100 | bizjournals.com Health Care:Biotechnology headlines
Dynavax Technologies Corp. started early testing of its universal flu vaccine. (DVAX) (Source: bizjournals.com Health Care:Biotechnology headlines)

Requiring masks motivates getting flu shot
Tue, 27 Jul 2010 05:19:18 +0100 | Health News - UPI.com
OTTAWA, July 27 (UPI) -- Campaigns can help persuade healthcare workers to get seasonal flu shots but requiring the unvaccinated to wear masks also works, Canadian researchers say. Influenza vaccine - Canada - Influenza - Health - Conditions and Diseases (Source: Health News - UPI.com)

Synthesis of 6-PEtN-Î±-D-GalpNAc-(1â€“>6)-Î²-D-Galp-(1â€“>4)-Î²-D-GlcpNAc-(1â€“>3)-Î²-D-Galp-(1â€“>4)-Î²-D-Glcp, a Haemophilus influenzae lipopolysacharide structure, and biotin and protein conjugates thereof
Mon, 26 Jul 2010 23:00:00 +0100 | Beilstein Journal of Organic Chemistry
Conclusion: An effective synthesis of a biologically interesting pentasaccharide structure has been accomplished. The target pentasaccharide, an α-GalNAc substituted lacto-N-neotetraose structure, comprises a phosphoethanolamine motif and a spacer aglycon. Through the spacer, biotin and protein conjugates of the title compound have been constructed to allow further use in biological experiments. Beilstein J. Org. Chem. 2010, 6. doi:10.3762/bjoc.6.80 (Source: Beilstein Journal of Organic Chemistry)